Trial Profile

Clinical Evaluation of the Sebum Reduction Induced by Clascoterone Cream 1%

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 24 Jun 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Clascoterone (Primary)
Indications Acne vulgaris
Focus Therapeutic Use

Most Recent Events

15 Jun 2026 Actual primary completion date changed from 18 Feb 2025 to 12 Feb 2025.
15 Apr 2025 Status changed from active, no longer recruiting to completed.
25 Oct 2024 According to a Sun Pharma media release, company announced today , interim analysis 16-week data from this trial will be presented in a poster at the 44th Annual Fall Clinical Dermatology Conference, being held Oct 24-27, 2024, in Las Vegas, Nevada.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com